TY - JOUR T1 - Drs. Schneeberger and Citera reply JF - The Journal of Rheumatology JO - J Rheumatol SP - 461 LP - 461 DO - 10.3899/jrheum.220821 VL - 50 IS - 3 AU - Emilce E. Schneeberger AU - Gustavo Citera Y1 - 2023/03/01 UR - http://www.jrheum.org/content/50/3/461.abstract N2 - To the Editor:We greatly appreciate the comments from Profs. Pincus and Schmukler.1 We strongly agree that the Routine Assessment of Patient Index Data 3 (RAPID3) is an excellent instrument to provide quantitative data on the status of our patients with axial spondyloarthritis (axSpA), as shown by the studies cited. Our group cross-culturally adapted and validated the RAPID3 in 51 consecutive patients aged ≥ 18 years diagnosed with axSpA (according to modified New York criteria 1987 and/or Assessment of SpondyloArthritis international Society [ASAS] 2009).2 … Address correspondence to Dr. E.E. Schneeberger, 155 Echeverría CABA, CP1428, Buenos Aires, Argentina. Email: eschneeb{at}gmail.com. ER -